Intellia Therapeutics (NTLA, $15.44) Moving Average Convergence Divergence (MACD) Histogram turned negative on July 9, 2026

#Biotechnology, #TechnicalAnalysis, #MACD, #Bearish, #Stocks, #MidCap, #Russel2000
NTLA - Intellia Therapeutics
MACD signal
Bearish Trend
90%
Odds of DOWN Trend
Price: $15.44
Daily change: -$1.4 (-8.31%)
Daily volume: 4.4M
Industry: Biotechnology

This is a Bearish indicator signaling NTLA's price could decline from here. Traders may explore shorting the stock or put options. A.I. dvisor identified 45 similar cases where NTLA's MACD histogram became negative, and 44 of them led to successful outcomes. Odds of Success: 90%.